Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Background and Hypothesis: The study aimed to compare the clinical picture and treatment differences in
elderly patients (aged 75 years or older) and younger patients (aged below 75 years).
Methods: The study included 80 consecutive patients with myocardial infarction (MI) treated in the Cardiology
Ward of the Specialist Hospital in Radom, Poland, in 2005. Analyses were performed retrospectively. The
patients were separated into 2 groups according to age. The group I study group consisted of 40 patients
aged 75 or over (aged 75–95; mean 81 years) and the group II control group consisted of 40 patients aged
below 75 years (aged 42–67; mean 60 years).
Results: In the elderly, as compared with younger subjects, dyspnea, fatigue, and other heart failure symptoms,
were more frequently the first symptoms of MI than typical chest pain (p<0.05). ST-segment elevation
myocardial infarction (STEMI) was also more common (p<0.05). Non-ST-segment elevation myocardial
infarction (NSTEMI) was more frequently diagnosed in the elderly (p<0.05). In elderly patients there were
more women (p<0.05), more patients with previously diagnosed ischemic heart disease (p<0.05), with
hypertension (p<0.05), and with diabetes mellitus (p<0.05). Obesity was less frequently diagnosed in the
elderly; however the difference was not statistically significant. Dyslipidemia and cigarette smoking were both
significantly less common among elderly patients (p<0.05). The elderly were significantly less frequently
revascularized (p<0.05). Both fibrinolysis and primary percutaneous coronary intervention (PCI) were less
commonly applied to the elderly (p<0.05). Time from symptom onset to hospital admission was significantly
longer in the case of elderly patients (p<0.05). The MI complications and side effects of treatment seemed to
be more frequent in the elderly, but only post-MI heart failure was observed more frequently in this group of
patients (p< 0.05).
Conclusions: Our observations confirm the differences in the clinical picture of MI in the elderly as described
previously. All patients of advanced age should be considered as having the highest risk of death and
complications occurrence.
significant. A family history of ischemic heart disease, PCI was performed on 42 patients in total, on 17 (44%) and 24
dyslipidemia, and cigarette smoking were significantly less (60%) of groups I and II, respectively. Elderly patients these
common (p<0.05) among elderly patients (Table 2). 2 invasive procedures performed—coronary angiography
Elderly patients had suffered from previous MIs more and PCI—significantly less frequently when compared to
frequently (p<0.05) and they had undergone coronary younger patients (p<0.05; Table 4).
angiography and PCI less frequently (p<0.05). Only 1 During the course of hospitalization, elderly patients
patient over 75 had had coronary artery bypass graft surgery rarely received angiotensin converting enzyme inhibitors
compared to none in the group of younger patients. There (ACE-I; p<0.05). Low molecular weight heparin was
was statistical significance in the higher frequency of elderly more often administered (p<0.05). Other medications
patients having been diagnosed with ischemic heart disease like aspirin, clopidogrel, beta-blockers, and unfractionated
before MI (p<0.05; Table 3). heparin (UFH), were used in both groups with the same
A total of 25 (31%) patients received thrombolytic treat- frequency (Table 5). As to MI complication, only recurrent
ment: 14 (34%) elderly and 11 (27%) younger patients, but the MI occurred more frequently in the elderly (p<0.05)
differences were not statistically significant (p>0.05). Coro- (Table 6).
nary angiography was performed on 54 (67.5%) patients in The time duration from symptom onset to hospital
total, on 20 (50%) and 34 (85%) of groups I and II, respectively. admission was significantly longer in the case of elderly
patients (p<0.05; Table 7). Mean time for the elderly was
5 h and 56 min contrasted to 3 h and 45 min for younger
Table 2. Cardiac risk factors profile
patients.
Risk factors Age ≥75 Age <75 p value The MI complications and side effects of treatment
seemed to be more frequent in the elderly, but only post-MI
Women 21 (52%) 14 (35%) p<0.05
heart failure was observed more frequently in patients of
Men 19 (65%) 26 (65%) p<0.05 group I (p<0.05).
Smoking 8 (20%) 21 (52%) p<0.05
Table 4. Reperfusion therapy
Hyperlipidemia 14 (35%) 17 (42%) p<0.05
Reperfusion therapy Age ≥75 Age <75 p value
History of IHD 28 (70%) 24 (60%) p<0.05
Thrombolysis 14 (34%) 11 (27%) NS
Hypertension 22 (55%) 18 (45%) p<0.05
Coronary angiography 20 (50%) 34 (85%) p<0.05
Diabetes mellitus 12 (30%) 5 (12%) p<0.05
PCI 17 (44%) 24 (60%) p<0.05
Obesity∗ 11 (27%) 12 (30%) NS
CABG 2 (5%) 1 (2.5%) NS
Family history∗∗ 8 (20%) 18 (45%) p<0.05
Abbreviations: CABG = coronary artery bypass grafting; PCI =
Abbreviation: IHD = ischemic heart disease. ∗ Obesity was defined as percutaneous coronary intervention.
BMI (body mass index) ≥30 kg/m2 . ∗∗ Family history is defined as any
clinical atherosclerosis in the family diagnosed in females before 65 and
in males before 55 years old.
Table 5. Medical treatment of MI
Abbreviations: CABG = coronary artery bypass grafting; IHD = ischemic Abbreviations: ACE-I = angiotensin converting enzyme inhibitors; ASA
heart disease; MI = myocardial infarction; PCI = percutaneous coronary = aspirin; AT1 = antiotensin type 1 receptor; LMWH = low molecular
intervention. weight heparin; UFH = unfractionated heparin.
was observed in many clinical studies and registries27 and 7. Kowalski J, Banach M, Barylski M, et al. Neutrophil superoxide
anion generation during atorvastatin and fluvastatin therapy
was confirmed in our small sample as well.
used in coronary heart disease primary prevention. J Cardiovasc
In the previous observations, an increasing gradient of Pharmacol. 2006;48:143–147.
mortality with increasing age was seen.20 In our study, 5 8. Rich MW. Epidemiology, clinical features, and prognosis of
patients of the elderly group and 2 of the younger individuals acute myocardial infarction in the elderly. Am J Geriatr Cardiol.
died in the hospital. The differences were not statistically 2006;15:7–11.
9. Thompson RC, Holmus DR Jr, Gersh BJ, Mock MB, Bailey
significant. The incidence of recurrent angina was observed
KR. Percutaneous transluminal coronary angioplasty in the
previously20 to be less frequent in the elderly. Such a trend elderly: early and long term results. J Am Coll Cardiol. 1991;17:
was also observed in our study, but it was not statistically 1245–1250.
significant. The only statistically significant difference in 10. Myocardial infarction redefined: a consensus document of The
post-MI complications between the elderly and younger Joint European Society of Cardiology/American College of
Cardiology Committee for Myocardial Infarction Redefinition. Eur
patients was a higher incidence of post-MI heart failure.28
Heart J. 2000;21:1502–1513.
11. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European
Limitations of the Study guidelines on cardiovascular disease prevention in clinical practice:
The retrospective nature of the study is an obvious Third joint task force of European and other societies on
cardiovascular disease prevention in clinical practice. European
methodological limitation. We also realized that the number
Heart J. 2003;24:1601–1610.
of patients in the study groups was small, which significantly 12. AIMS Trial Study Group. Effect of intravenous APSAC on mortality
limits our conclusions from the observations. However, after acute myocardial infarction: preliminary report of a placebo
the results of our observations are consistent with those controlled trial. Lancet. 1989;1:545–549.
reported previously. 13. Chesbro JH; TIMI Investigators. Thrombolysis in Myocardial
Infarction (TIMI) trial. Phase I: a comparison between intravenous
In conclusion, our observations confirmed the differences
tissue plasminogen activator and intravenous streptokinase.
in the clinical picture of MI between older and younger Circulation. 1987;76:142–154.
individuals in many aspects. The elderly present less typical 14. Akiyama J, Aonuma K, Nogami A, et al. Thrombolytic therapy
symptoms of MI, which is followed by the significant delay can reduce the arrhythmogenic substrate after acute myocardial
in diagnosis and initiation of the treatment. This group infarction: a study using the signal-averaged electrocardiogram,
endocardial catheter mapping and programmed ventricular
also has different cardiac risk factor profile characteristics. stimulation. Circ J. 1999;63:838–842.
Despite the fact that the elderly constitute a group at 15. Banach M, Drożdż J, Okonski P, Rysz J. Immunological aspects
high cardiovascular risk, the most effective methods of of the statins’ function in patients with heart failure: a report from
MI treatment, such as reperfusion procedures including the Annual Conference of ESC—Heart Failure 2005. Cell Mol
PCI, are performed significantly less often when compared Immunol. 2005;2:433–437.
16. Muller RT, Gould LA, Betzu RY, Vacek T, Pradeek V. Painless
to younger MI patients. The majority of differences noticed myocardial infarction in the elderly. Am Heart J. 1990;119:
in our small sample have been observed previously. 202–204.
17. Gregoratos G. Clinical manifestations of acute myocardial
References infarction in older patients. Am J Geriatr Cardiol. 2001;10:
1. Kitazume H, Kubo I, Iwama T, Ageishi Y, Suzuki A. Percutaneous 345–347.
transluminal coronary angioplasty for elderly patients. Circ J. 18. Miller PF, Sheps DS, Bragdon EE, et al. Aging and pain perception
1988;52:449–453. in ischemic heart disease. Am Heart J. 1990;12:22–27.
2. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary 19. Bayer AL, Chadha JS, Farag RR, Pathy MS. Changing presentation
outcome trends in the elderly undergoing percutaneous coronary of myocardial infarction with increasing old age. J Am Geriatr Soc.
interventions: results in 7,472 octogenarians. J Am Coll Cardiol. 1986;34:263–269.
2000;36:723–30. 20. Paul DS, O’Gara PT, Mahjoub ZA, et al. Geriatric patients with
3. DeGeare VS, Stone GW, Grines L. Angiographic and clinical acute myocardial infarction: cardiac risk profiles, presentation,
characteristics associated with increased in-hospital mortality thrombolysis, coronary interventions, and prognosis. Am Heart J.
in elderly patients with acute myocardial infarction undergoing 1996;131:710–715.
percutaneous intervention (A pooled analysis of the primary 21. Haase KK, Schiele R, Wagner S, et al. In-hospital mortality of
angioplasty in myocardial infarction trials). Am J Cardiol. elderly patients with acute myocardial infarction: data from MITRA
2000;86:30–34. (Maximal Individual Therapy in Acute Myocardial Infarction)
4. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day registry. Clin Cardiol. 2000;23:831–836.
mortality in the era of reperfusion for acute myocardial infarction: 22. Smith SC, Gilpin E, Ahnve S, et al. Outlook after acute myocardial
results from an international trial of 41,021 patients. Circulation. infarction in the very elderly compared with that in patients aged
1995;91:1659–1668. 65 to 75 years. J Am Coll Cardiol. 1990;16:784–792.
5. Devlin W, Cragg D, Jacks M. Comparison of outcome in patients 23. Matetzky S, Sharir T, Moc M, et al. Primary angioplasty for
with acute myocardial infarction aged 75 years with that in younger acute myocardial infarction in octogenarians. Am J Cardiol.
patients. Am J Cardiol. 1995;75:573–576. 2001;88:680–683.
6. Grines CL, Westerhausen DR, Grines LL, et al; Air PAMI Study 24. Banach M, Goch A, Misztal M, et al. Low output syndrome
Group. A randomized trial of transfer for primary angioplasty following aortic valve replacement: predictors and prognosis. Arch
versus on-site thrombolysis in patients with high-risk myocardial Med Sci. 2007;3:117–122.
infarction: the air primary angioplasty in myocardial infarction 25. Harpaz D, Rozenman Y, Behar S, et al. Israeli Working Group on
study. J Am Coll Cardiol. 2002;39(11):1713–1719. Intensive Cardiac Care, Israel Heart Society: coronary angiography